Retour sur lavenir.net
   TUBIZE-FIN 217.600 € (-0,27 %)     EKOPAK 4.000 € (+1,78 %)     AB INBEV 70.480 € (+0,09 %)     UCB 247.500 € (-0,68 %)     ARGENX SE 769.400 € (+0,87 %)     ELIA GROUP 131.300 € (-0,30 %)     COLRUYT 34.100 € (-0,06 %)     NYRSTAR 0.065 € (0,00 %)     AGEAS 67.550 € (+0,52 %)     KBC 119.550 € (+0,42 %)     BPOST 1.610 € (-0,37 %)     SOLVAY 27.400 € (-1,44 %)     SOFINA 222.000 € (+0,27 %)     KBC ANCORA 82.000 € (+0,24 %)     WDP 21.680 € (-0,28 %)     D'IETEREN GROUP 161.600 € (-2,06 %)     GBL 79.300 € (0,00 %)     BANQUP GROUP 2.620 € (+11,02 %)     AZELIS GROUP 9.875 € (+0,77 %)     SYENSQO 67.350 € (-0,37 %)     UMICORE 22.900 € (-3,46 %)     PROXIMUS 6.140 € (-0,41 %)     RECTICEL 10.980 € (+1,10 %)     BARCO 8.590 € (-1,15 %)     DECEUNINCK 2.305 € (+1,32 %)     MELEXIS 81.550 € (-1,75 %)     IBA 16.590 € (+3,04 %)     MONTEA 65.700 € (-0,30 %)     NYXOAH 1.418 € (+1,29 %)     EVS 29.550 € (-0,17 %)     AEDIFICA 68.000 € (+0,07 %)     VGP 82.000 € (-0,49 %)     RETAIL ESTATES 68.600 € (-0,44 %)     VIOHALCO 20.700 € (+4,86 %)     COFINIMMO 80.000 € (+0,44 %)     CMB.TECH 12.600 € (+1,45 %)     ACKERMANS V.HAAREN 286.600 € (-0,42 %)     SHURGARD 23.950 € (-0,83 %)     FLUXYS BELGIUM D 19.650 € (0,00 %)     CENERGY 25.260 € (+1,12 %)     TITAN S.A. 53.350 € (-1,75 %)     HOME INVEST BE. 19.400 € (0,00 %)     TESSENDERLO 20.700 € (+0,49 %)     CFE 12.800 € (+1,59 %)     KINEPOLIS GROUP 35.250 € (-0,56 %)     CAMPINE 223.000 € (+0,45 %)     BREDERODE 102.200 € (-0,20 %)     SIPEF 92.600 € (+0,11 %)     CELYAD ONCOLOGY 0.250 € (-6,37 %)     OPTION 5.960 € (-5,10 %)     BIOTALYS 3.200 € (+0,16 %)     ONWARD MEDICAL 2.640 € (-0,75 %)     IMMOBEL 23.100 € (-3,75 %)     TINC 11.640 € (0,00 %)     BEKAERT 41.800 € (-0,71 %)     ASCENCIO 52.000 € (+0,58 %)     WERELDHAVE BELGIUM 52.600 € (+0,77 %)     XIOR 26.050 € (+0,19 %)     JENSEN-GROUP 84.400 € (+1,69 %)     DEME GROUP 181.400 € (-0,22 %)  
   EXOSENS 60.750 € (+2,02 %)     FDJ UNITED 22.370 € (-0,71 %)     CVC CAPITAL 12.930 € (-0,84 %)     VIRIDIEN 92.050 € (+2,11 %)     AYVENS 11.770 € (-1,09 %)     OPMOBILITY 14.120 € (-0,77 %)     LIGHTON 6.150 € (+3,36 %)     CSG 14.332 € (+0,48 %)     PROSUS 38.730 € (-0,92 %)     SANOFI 74.850 € (+2,06 %)     DSM FIRMENICH AG 77.100 € (+0,50 %)     PLANISWARE 18.020 € (+0,11 %)     AXA 42.550 € (+0,35 %)     DANONE 65.280 € (-0,64 %)     VIEL ET COMPAGNIE 17.720 € (-0,45 %)     DASSAULT AVIATION 301.600 € (+0,13 %)     WOLTERS KLUWER 58.600 € (+0,69 %)     SENSORION 0.264 € (+14,07 %)     ASML HOLDING 1 668.400 € (-0,45 %)     SCOR SE 31.280 € (+0,45 %)     ALSTOM 16.130 € (-0,43 %)     ADYEN 889.500 € (-1,58 %)     BAM GROEP KON 12.490 € (0,00 %)     ASM INTERNATIONAL 1 056.500 € (-1,31 %)     ARCELORMITTAL SA 55.320 € (-0,97 %)     SOCIETE GENERALE 78.150 € (+0,13 %)     BE SEMICONDUCTOR 310.100 € (-2,42 %)     AVANTIUM 7.980 € (-0,25 %)     CAPGEMINI 89.220 € (+0,25 %)     BOLLORE 5.545 € (+2,69 %)     PHILIPS KON 23.340 € (-0,68 %)     OVH 16.530 € (-5,22 %)     EURONEXT 146.200 € (-0,07 %)     HEINEKEN HOLDING 63.350 € (-0,78 %)     VALEO 13.535 € (+0,93 %)     AHOLD DEL 34.725 € (+0,59 %)     VINCI 129.750 € (-0,69 %)     EDP RENEWABLES 13.510 € (-0,07 %)     STELLANTIS NV 5.615 € (+0,81 %)     UNILEVER 50.480 € (-0,75 %)     FORVIA 9.450 € (+0,45 %)     PERNOD RICARD 63.460 € (-0,63 %)     HERMES INTL 1 729.000 € (-1,93 %)     COVIVIO 53.600 € (-0,19 %)     BNP PARIBAS ACT.A 101.240 € (+0,14 %)     THERACLION 0.682 € (-9,07 %)     SAINT GOBAIN 78.920 € (-1,05 %)     AIR LIQUIDE 166.500 € (-0,37 %)     LVMH 506.300 € (+0,24 %)     ASR NEDERLAND 66.080 € (+0,73 %)     SARTORIUS STED BIO 163.200 € (-1,39 %)     DASSAULT SYSTEMES 17.125 € (+0,26 %)     EUTELSAT COMMUNIC. 2.371 € (-0,17 %)     L'OREAL 376.950 € (-2,72 %)     KERING 271.600 € (-1,79 %)     KLEPIERRE 35.420 € (-1,28 %)     TKH GROUP 44.420 € (-0,63 %)     X-FAB 9.070 € (-8,48 %)     MICHELIN 33.470 € (+0,21 %)     KPN KON 4.335 € (+0,32 %)  
News Réglementées
17/02/2023 13:07

EXASOL AG: Exasol announces preliminary figures for 2022, outlook for 2023 and need to adjust the 2025 mid-term target

EQS-News: EXASOL AG / Key word(s): Preliminary Results/Forecast
EXASOL AG: Exasol announces preliminary figures for 2022, outlook for 2023 and need to adjust the 2025 mid-term target

17.02.2023 / 13:07 CET/CEST
The issuer is solely responsible for the content of this announcement.


Exasol announces preliminary figures for 2022, outlook for 2023 and the need to adjust the 2025 mid-term target

- ARR increased by 17% to EUR 35.6 million in 2022 (guidance: EUR 35.5 million to EUR 37.0 million)
- Adjusted EBITDA improves to EUR -13.4 million (previous year: EUR -31.6 million) and reaching the upper end of forecast range (guidance: EUR -14 million to EUR -13 million)
- Liquid funds reach EUR 12.7 million at year-end
(guidance: EUR 12 million to EUR 13 million)
- Outlook 2023: Accelerated growth and further strong improvement in profitability expected
- Achieving the mid-term target of EUR 100 million ARR in 2025 no longer likely

Nuremberg, February 17, 2023: Exasol AG, a global technology company and provider of a high-performance analytics database, has increased recurring revenues (ARR) to EUR 35.6 million in fiscal year 2022, according to preliminary figures. This corresponds to an increase of 17% and was in line with management expectations, which were adjusted to a range of EUR 35.5 million to EUR 37.0 million in November 2022. For 2022, the company met it’s expected target for profitability and liquidity: the operating result (adj. EBITDA) improved significantly to EUR -13.4 million, compared with a loss of EUR -31.6 million in the previous year. The company further met its target of liquid funds which stood at EUR 12.7 million at the end of 2022.

“Our efficiency improvement measures progressed well last year. Despite challenging market conditions, we increased our revenue and improved operational efficiencies," explains Jörg Tewes, CEO of Exasol since January 1, 2023. "Our aim for the years ahead is to strike a good equilibrium between growth and profitability. This remains extremely important to us especially in the current economic environment.”

Outlook 2023

For the current fiscal year, the Executive Board anticipates both a continuation of the existing growth course and an acceleration in profitability: with an increase in ARR to EUR 42.5 million to EUR 44 million in fiscal year 2023, the Executive Board expects adj. EBITDA to improve further to EUR -3 million to EUR -1 million. The aim is to achieve profitability on a quarterly basis as early as the second half of the current fiscal year. Accordingly, liquid funds will be virtually unchanged at EUR 9 million to EUR 11 million at the end of the year.

"We will accelerate our growth this year compared to the previous year and make Exasol sustainably profitable," says Jörg Tewes, CEO of Exasol. "This will make us more independent of market fluctuations, strengthen our internal financing power and put the company in a more robust position overall."

Need to adjust mid-term target 2025

As a result of Exasol’s strategy to focus even more on profitability and considering the more challenging economic environment, the Executive Board does no longer consider that the originally advised mid-term target of achieving an ARR of EUR 100 million in 2025 is likely. It will therefore reassess the growth scenarios as part of its strategic planning and based on the current market environment, and will update the medium-term target at a given time.

The complete and audited 2022 Annual Report will be published on May 10, 2023.

Exasol AG
Christoph Marx
Head of Investor Relations
Tel: +49 911 2399 114
E-Mail: ir@exasol.com



17.02.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language:English
Company:EXASOL AG
Neumeyerstraße 22-26
90411 Nuremberg
Germany
Internet:www.exasol.com
ISIN:DE000A0LR9G9
WKN:A0LR9G
Listed:Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID:1563047

 
End of NewsEQS News Service

1563047  17.02.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1563047&application_name=news&site_id=symex

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière